Latest Development Pipeline News

Bega Cheese Limited reported robust FY2025 results marked by strategic site consolidations, innovation-led growth, and a strong financial position, setting the stage for an optimistic FY2026.

Karoon Energy reported a 12% production dip in Q3 2025 due to operational challenges but saw a 3% revenue increase driven by higher oil prices and secured a new deepwater block in Brazil.

National Storage REIT delivered robust FY25 results, surpassing earnings guidance and expanding its development pipeline, while advancing sustainability and technology initiatives.

Mirvac Group reported a strong start to FY26 with a 79% surge in residential lot sales and a strategic joint venture with Mitsubishi Estate unlocking $450 million in capital. The company reaffirmed its full-year earnings guidance amid robust leasing and development progress.

Noxopharm Limited has been granted its first US patent for the Sofra™ technology platform, marking a key milestone in its cancer immunotherapy research. This patent protects the company’s innovative immune-modulatory oligonucleotides, underpinning its expanding pipeline in a rapidly growing market.

Imagion Biosystems has made significant strides toward filing an IND application for its MagSense® HER2 breast cancer imaging agent, supported by positive FDA feedback and a recent $3.5 million capital raise to fund upcoming clinical trials.

Horizon Minerals reported steady gold production from Boorara and Phillips Find, unveiled promising high-grade drilling results at Burbanks, and acquired the Gordons Project near Black Swan, while progressing a key Pre-Feasibility Study for a gold processing plant conversion.

Vectus Biosystems has requested an immediate suspension of its ASX-listed shares pending a significant announcement about a transaction involving a compound in its drug library.

Stockland has reaffirmed its FY26 financial guidance following a strong first quarter marked by solid sales in masterplanned and land lease communities and positive leasing outcomes across its commercial portfolio.

Finbar Group Limited’s 2025 AGM confirmed strong shareholder support for key resolutions as the company reported record sales and unveiled a robust $1.2 billion development pipeline focused on mid-market apartments in Perth.

Actinogen Medical has secured an initial $5.5 million R&D tax incentive rebate from the Australian Tax Office, with an additional $1.9 million pending, bolstering funding for its Alzheimer’s and depression drug trials.

IsoEnergy Ltd. has agreed to acquire Toro Energy Ltd. in a deal that significantly expands its uranium portfolio, adding the Wiluna Uranium Project in Western Australia and creating a diversified, top-tier uranium development platform.